Literature DB >> 24582908

A critical role for prefrontocortical endocannabinoid signaling in the regulation of stress and emotional behavior.

Ryan J McLaughlin1, Matthew N Hill2, Boris B Gorzalka3.   

Abstract

The prefrontal cortex (PFC) provides executive control of the brain in humans and rodents, coordinating cognitive, emotional, and behavioral responses to threatening stimuli and subsequent feedback inhibition of the hypothalamic-pituitary-adrenal (HPA) axis. The endocannabinoid system has emerged as a fundamental regulator of HPA axis feedback inhibition and an important modulator of emotional behavior. However, the precise role of endocannabinoid signaling within the PFC with respect to stress coping and emotionality has only recently been investigated. This review discusses the current state of knowledge regarding the localization and function of the endocannabinoid system in the PFC, its sensitivity to stress and its role in modulating the neuroendocrine and behavioral responses to aversive stimuli. We propose a model whereby steady-state endocannabinoid signaling in the medial PFC indirectly regulates the outflow of pyramidal neurons by fine-tuning GABAergic inhibition. Local activation of this population of CB1 receptors increases the downstream targets of medial PFC activation, which include inhibitory interneurons in the basolateral amygdala, inhibitory relay neurons in the bed nucleus of the stria terminalis and monoamine cell bodies such as the dorsal raphe nucleus. This ultimately produces beneficial effects on emotionality (active coping responses to stress and reduced anxiety) and assists in constraining activation of the HPA axis. Under conditions of chronic stress, or in individuals suffering from mood disorders, this system may be uniquely recruited to help maintain appropriate function in the face of adversity, while breakdown of the endocannabinoid system in the medial PFC may be, in and of itself, sufficient to produce neuropsychiatric illness. Thus, we suggest that endocannabinoid signaling in the medial PFC may represent an attractive target for the treatment of stress-related disorders.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Emotional behavior; Endocannabinoid system; Prefrontal cortex; Stress

Mesh:

Substances:

Year:  2014        PMID: 24582908     DOI: 10.1016/j.neubiorev.2014.02.006

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  47 in total

1.  Chronic Hormonal Imbalance and Adipose Redistribution Is Associated with Hypothalamic Neuropathology following Blast Exposure.

Authors:  Pamela J VandeVord; Venkata Siva Sai Sujith Sajja; Evon Ereifej; Amy Hermundstad; Shijie Mao; Timothy J Hadden
Journal:  J Neurotrauma       Date:  2015-08-14       Impact factor: 5.269

Review 2.  Sexually-dimorphic alterations in cannabinoid receptor density depend upon prenatal/early postnatal history.

Authors:  Diana Dow-Edwards; Ashley Frank; Dean Wade; Jeremy Weedon; Sari Izenwasser
Journal:  Neurotoxicol Teratol       Date:  2016-09-12       Impact factor: 3.763

3.  The Lateral Habenula Directs Coping Styles Under Conditions of Stress via Recruitment of the Endocannabinoid System.

Authors:  Anthony L Berger; Angela M Henricks; Janelle M Lugo; Hayden R Wright; Collin R Warrick; Martin A Sticht; Maria Morena; Itziar Bonilla; Sarah A Laredo; Rebecca M Craft; Loren H Parsons; Pedro R Grandes; Cecilia J Hillard; Matthew N Hill; Ryan J McLaughlin
Journal:  Biol Psychiatry       Date:  2018-05-08       Impact factor: 13.382

4.  Activation of cannabinoid system in anterior cingulate cortex and orbitofrontal cortex modulates cost-benefit decision making.

Authors:  Abbas Khani; Mojtaba Kermani; Soghra Hesam; Abbas Haghparast; Enrike G Argandoña; Gregor Rainer
Journal:  Psychopharmacology (Berl)       Date:  2014-12-23       Impact factor: 4.530

5.  Blunted stress reactivity in chronic cannabis users.

Authors:  Carrie Cuttler; Alexander Spradlin; Amy T Nusbaum; Paul Whitney; John M Hinson; Ryan J McLaughlin
Journal:  Psychopharmacology (Berl)       Date:  2017-05-31       Impact factor: 4.530

6.  Chronic Stress Increases Prefrontal Inhibition: A Mechanism for Stress-Induced Prefrontal Dysfunction.

Authors:  Jessica M McKlveen; Rachel L Morano; Maureen Fitzgerald; Sandra Zoubovsky; Sarah N Cassella; Jessie R Scheimann; Sriparna Ghosal; Parinaz Mahbod; Benjamin A Packard; Brent Myers; Mark L Baccei; James P Herman
Journal:  Biol Psychiatry       Date:  2016-03-28       Impact factor: 13.382

Review 7.  Anxiety, Depression, and the Microbiome: A Role for Gut Peptides.

Authors:  Gilliard Lach; Harriet Schellekens; Timothy G Dinan; John F Cryan
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

8.  Cortical adrenoceptor expression, function and adaptation under conditions of cannabinoid receptor deletion.

Authors:  B A S Reyes; A F Carvalho; P Szot; D J Kalamarides; Q Wang; L G Kirby; E J Van Bockstaele
Journal:  Exp Neurol       Date:  2017-03-21       Impact factor: 5.330

9.  Involvement of M1 and CB₁ receptors in the anxiogenic-like effects induced by neostigmine injected into the rat prelimbic medial prefrontal cortex.

Authors:  M V Fogaça; A G Fedoce; N C Ferreira-Junior; F S Guimarães; L B Resstel
Journal:  Psychopharmacology (Berl)       Date:  2016-02-13       Impact factor: 4.530

10.  Morphological and behavioral evidence for impaired prefrontal cortical function in female CB1 receptor deficient mice.

Authors:  Tiffany T-Y Lee; Sarah B Filipski; Matthew N Hill; Bruce S McEwen
Journal:  Behav Brain Res       Date:  2014-06-04       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.